In response to these findings, the European Medicines Agency (EMA) conducted a review and concluded that NAION is a very rare adverse reaction to semaglutide-containing products, potentially affecting up to 1 in 10,000 users
[But now I realize] there are patients who would benefit from these medications. He emphasizes that, when prescribed in concert with other comprehensive lifestyle interventions, including physical therapy, resistance training, and healthy eating, GLP-1s can be promising, so long as clinicians proceed with caution
10.1097/WNR.0000000000000046 96
K., McCulloch, C
Retatrutide may support fat loss as body weight decreases, but it is not simply a fat-burning injection
Your medical team will recommend the best option based on your goals and health profile